Mizobuchi Masahide

Researcher

基本情報

Profile and Settings

• 氏名

  Mizobuchi Masahide

Affiliation

• Nephrology, Associate Professor

Location

• Fujigaoka Hospital

Degree

• Doctor of Medical Science, Wakayama Medical University, Mar. 2005

Achievements

Published Papers

• Lower soluble Klotho levels in the pretransplant period are associated with an increased risk of renal function decline in renal transplant patients, Yasuto Shikida; Masahide Mizobuchi; Osamu Yoshitake; Tadashi Kato; Hiroaki Ogata; Fumihiko Koiwa; Hirokazu Honda, THERAPEUTIC APHERESIS AND DIALYSIS, 25(3):331 - 340, Jun. 2021, Peer-reviewed, DOI:10.1111/1744-9987.13578
• Tumoral calcinosis due to severe hyperphosphatemia and secondary hyperparathyroidism without vascular calcification in a hemodialysis patient., Tomohiro Saito; Masahide Mizobuchi; Toma Hamada; Motonori Sugiyama; Nozomi Miyazawa; Tomoki Morikawa; Kei Matsumoto; Osamu Yoshitake; Takeshi Aoki; Masahiko Murakami; Hirokazu Honda, Clinical nephrology, 95(3):166 - 170, Mar. 2021, Peer-reviewed
• Anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis with rapidly progressive interstitial lung disease treated with therapeutic plasma exchange: A case series., SAITO Tomohiro;MIZOBUCHI Masahide;MIWA Yusuke;SUGIYAMA Motonori;MIMA Yuuki;IIDA Ayana;KANAZAWA Nobuhiro;MORIKAWA Tomoki;HAYASHI Junichi;FUKUDA Kei;SHIKIDA Yasuto;SUZUKI Taihei;HONDA Hirokazu, J Clin Apher, 36(1):196 - 205, Feb. 2021, Peer-reviewed, DOI:10.1002/jca.21833
• Osteoblastic differentiation of bone marrow mesenchymal stem cells in uremic rats., KATO Tadashi;MIZOBUCHI Masahide;SASA Kiyohito;YAMADA Atsushi;OGATA Hiroaki;HONDA Hirokazu;SAKASHITA Akiko;KAMIJO Ryutaro, Biochem Biophys Res Commun, 532(1):11 - 18, Oct. 2020, Peer-reviewed
• Early response of the parathyroid gland to withdrawal of a calcimimetic compound in uremic rats., Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Hirokazu Honda, American journal of physiology. Renal physiology, 318(3):F639-F646, Mar. 2020
• Early response of the parathyroid gland to withdrawal of a calcimimetic compound in uremic rats., Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Hirokazu Honda, American journal of physiology. Renal physiology, 318(3):F639-F646, Mar. 2020
• Early response of the parathyroid gland to withdrawal of a calcimimetic compound in uremic rats., Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Hirokazu Honda, American journal of physiology. Renal physiology, 318(3):F639-F646, Mar. 2020
• Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility., Tomohiro Saito; Yuuki Mima; Motonori Sugiyama; Nozomi Miyazawa; Ayana Iida; Nobuhiro Kanazawa; Taihei Suzuki; Yasuto Shikida; Toma Hamada; Yukihiro Wada; Masahide Mizobuchi; Hirokazu Honda, CEN case reports, 9(2):122 - 128, Dec. 2019
• Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility., Tomohiro Saito; Yuuki Mima; Motonori Sugiyama; Nozomi Miyazawa; Ayana Iida; Nobuhiro Kanazawa; Taihei Suzuki; Yasuto Shikida; Toma Hamada; Yukihiro Wada; Masahide Mizobuchi; Hirokazu Honda, CEN case reports, 9(2):122 - 128, Dec. 2019
• Multidisciplinary management of calciphylaxis: a series of 5 patients at a single facility., Tomohiro Saito; Yuuki Mima; Motonori Sugiyama; Nozomi Miyazawa; Ayana Iida; Nobuhiro Kanazawa; Taihei Suzuki; Yasuto Shikida; Toma Hamada; Yukihiro Wada; Masahide Mizobuchi; Hirokazu Honda, CEN case reports, 9(2):122 - 128, Dec. 2019
• Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment., Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 23(4):309 - 318, Aug. 2019
• Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment., Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 23(4):309 - 318, Aug. 2019
• Secondary Hyperparathyroidism: Pathogenesis and Latest Treatment., Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 23(4):309 - 318, Aug. 2019
• Effect of Continuous Intravenous Calcium Loading on Fibroblast Growth Factor 23 in Normal and Uremic Rats., Yasuto Shikida; Masahide Mizobuchi; Takashi Inoue; Toma Hamada; Hiroaki Ogata; Fumihiko Koiwa; Takanori Shibata, Calcified tissue international, 103(4):455 - 464, Oct. 2018
• Effect of Continuous Intravenous Calcium Loading on Fibroblast Growth Factor 23 in Normal and Uremic Rats., Yasuto Shikida; Masahide Mizobuchi; Takashi Inoue; Toma Hamada; Hiroaki Ogata; Fumihiko Koiwa; Takanori Shibata, Calcified tissue international, 103(4):455 - 464, Oct. 2018
• Effect of Continuous Intravenous Calcium Loading on Fibroblast Growth Factor 23 in Normal and Uremic Rats., Yasuto Shikida; Masahide Mizobuchi; Takashi Inoue; Toma Hamada; Hiroaki Ogata; Fumihiko Koiwa; Takanori Shibata, Calcified tissue international, 103(4):455 - 464, Oct. 2018
• The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study., OGATA Hiroaki;KUMASAWA J;FUKUMA S;MIZOBUCHI Masahide;KINUGASA Eriko;FUKAGAWA M;FUKUHARA S;AKIZAWA Tadao, Clin Exp Nephrol, 21(5):797 - 806, Oct. 2017, Peer-reviewed
• RAS Inhibitor Is Not Associated With Cardiovascular Benefits in Patients Undergoing Hemodialysis in Japan., MIZOBUCHI Masahide;OGATA Hiroaki;ONISHI Yoshihiro;FUKUMA Shingo;AKIZAWA Tadao;FUKUHARA Shunichi, Ther Apher Dial, 21(4):326 - 333, Aug. 2017, Peer-reviewed
• Research on kidney and mineral metabolism in Japan: past, present, and future., MIZOBUCHI Masahide;OGATA Hiroaki;KOIWA Fumihiko;KINUGASA Eriko;AKIZAWA Tadao, Clin Exp Nephrol, 21(Suppl 1):4 - 8, Mar. 2017, Peer-reviewed
• Cardiac effect of vitamin D receptor modulators in uremic rats., MIZOBUCHI Masahide;OGATA Hiroaki;YAMAZAKI-NAKAZAWA Ai;HOSAKA Nozomu;KONDO Fumiko;KOIWA Fumihiko;KINUGASA Eriko;SHIBATA Takanori, J Steroid Biochem Mol Biol, 163:20 - 27, Oct. 2016, Peer-reviewed
• 重篤な肝不全を合併した常染色体優性多発性嚢胞腎の1透析例, 齋藤　友広;猪口　貴子;橘　翔平;日原　桂;濱田　透眞;溝渕　正英;柴田　孝則, 日本透析医学会雑誌, 49(8):547 - 551, Aug. 2016, Peer-reviewed
• PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism., Tadao Akizawa; Noriaki Kurita; Masahide Mizobuchi; Masafumi Fukagawa; Yoshihiro Onishi; Takuhiro Yamaguchi; Alan R Ellis; Shingo Fukuma; M Alan Brookhart; Takeshi Hasegawa; Kiyoshi Kurokawa; Shunichi Fukuhara, Scientific reports, 6:19612 - 19612, Apr. 2016
• PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism, AKIZAWA Tadao;KURITA N.;MIZOBUCHI Masahide;FUKAGAWA M.;ONISHI Y.;YAMAGUCHI T.;ELLIS A. R.;FUKUMA S.;ALAN BROOKHART M.;HASEGAWA Takeshi;KUROKAWA K.;FUKUHARA S., Sci Rep, 6:19612, Apr. 2016, Peer-reviewed
• Myocardial SPECT Images in Incident Hemodialysis Patients Without Ischemic Heart Disease, KOYAMA‐NAKAMURA Mari;MIZOBUCHI Masahide;KANEKO Kyoichi;WATANABE Makoto;OGATA Hiroaki;KOIWA Fumihiko;AIZAWA Tadao;AKUTSU Yasushi;SHIBATA Takanori, Ther Apher Dial, 19(6):575 - 581, Dec. 2015, Peer-reviewed
• Is there a need for new phosphate binders to treat phosphate imbalance associated with chronic kidney disease?, Jinshyun Ruth Wu-Wong; Masahide Mizobuchi, Expert opinion on investigational drugs, 23(11):1465 - 75, Nov. 2014
• Clinical uses of 22-oxacalcitriol., Masahide Mizobuchi; Hiroaki Ogata, Current vascular pharmacology, 12(2):324 - 8, Mar. 2014
• Correction of hyperphosphatemia suppresses cardiac remodeling in uremic rats., Ai Yamazaki-Nakazawa; Masahide Mizobuchi; Hiroaki Ogata; Chiaki Kumata; Fumiko Kondo; Naoko Ono; Fumihiko Koiwa; Susumu Uda; Eriko Kinugasa; Tadao Akizawa, Clinical and experimental nephrology, 18(1):56 - 64, Feb. 2014
• Intravenous phosphate loading increases fibroblast growth factor 23 in uremic rats., Noriko Arai-Nunota; Masahide Mizobuchi; Hiroaki Ogata; Ai Yamazaki-Nakazawa; Chiaki Kumata; Fumiko Kondo; Nozomu Hosaka; Fumihiko Koiwa; Eriko Kinugasa; Takanori Shibata; Tadao Akizawa, PloS one, 9(3):e91096, 2014
• Mechanistic analysis for time-dependent effects of cinacalcet on serum calcium, phosphorus, and parathyroid hormone levels in 5/6 nephrectomized rats., J Ruth Wu-Wong; Masaki Nakane; Yung-Wu Chen; Masahide Mizobuchi, Physiological reports, 1(3):e00046, Aug. 2013
• Vitamin D receptor activators inhibit vascular smooth muscle cell mineralization induced by phosphate and TNF-α., Yumie Aoshima; Masahide Mizobuchi; Hiroaki Ogata; Chiaki Kumata; Ai Nakazawa; Fumiko Kondo; Naoko Ono; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 27(5):1800 - 6, May 2012
• Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism., Masahiro Yamamoto; Hiroaki Ogata; Masahide Mizobuchi; Noriyo Yoshida; Chiaki Kumata-Maeta; Fumihiko Koiwa; Kanji Shishido; Eriko Kinugasa, Clinical and experimental nephrology, 16(2):292 - 9, Apr. 2012
• Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic rats., Chiaki Kumata; Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Fumiko Kondo; Eriko Kinugasa; Tadao Akizawa, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 15 Suppl 1:18 - 22, Jun. 2011
• Effects of calcimimetic combined with an angiotensin-converting enzyme inhibitor on uremic cardiomyopathy progression., Masahide Mizobuchi; Hiroaki Ogata; Nozomu Hosaka; Chiaki Kumata; Ai Nakazawa; Fumiko Kondo; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa, American journal of nephrology, 34(3):256 - 67, 2011
• Biocompatible characteristics of high-performance membranes., Susumu Uda; Masahide Mizobuchi; Tadao Akizawa, Contributions to nephrology, 173:23 - 29, 2011
• Detection of peripheral artery disease by duplexultrasonography among hemodialysis patients., OGATA Hiroaki;KUMATA-MAETA Chiaki;SHISHIDO Kanji;MIZOBUCHI Masahide;YAMAMOTO Masahiro;KOIWA Fumihiko;KINUGASA Eriko;AKIZAWA Tadao, Clin J Am Soc Nephrol, 5(12):2199 - 2206, Dec. 2010, Peer-reviewed
• Myocardial effects of VDR activators in renal failure., Masahide Mizobuchi; Hironori Nakamura; Masanori Tokumoto; Jane Finch; Jeremiah Morrissey; Helen Liapis; Eduardo Slatopolsky, The Journal of steroid biochemistry and molecular biology, 121(1-2):188 - 92, Jul. 2010
• Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism., Chiaki Kumata; Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Ai Nakazawa; Fumiko Kondo; Yoshiyuki Kadokura; Eriko Kinugasa; Tadao Akizawa, American journal of nephrology, 31(3):230 - 8, 2010
• Novel markers of left ventricular hypertrophy in uremia., Hironori Nakamura; Masanori Tokumoto; Masahide Mizobuchi; Cynthia S Ritter; Jane L Finch; Masanori Mukai; Eduardo Slatopolsky, American journal of nephrology, 31(4):292 - 302, 2010
• Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells., Nozomu Hosaka; Masahide Mizobuchi; Hiroaki Ogata; Chiaki Kumata; Fumiko Kondo; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa, Calcified tissue international, 85(6):523 - 9, Dec. 2009
• Calcium-sensing receptor expression is regulated by glial cells missing-2 in human parathyroid cells., Masahide Mizobuchi; Cynthia S Ritter; Irina Krits; Eduardo Slatopolsky; Gregorio Sicard; Alex J Brown, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 24(7):1173 - 9, Jul. 2009
• Vitamin D and vascular calcification in chronic kidney disease., Masahide Mizobuchi; Hiroaki Ogata; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa, Bone, 45 Suppl 1:S26-9, Jul. 2009
• Vascular calcification: the killer of patients with chronic kidney disease., Masahide Mizobuchi; Dwight Towler; Eduardo Slatopolsky, Journal of the American Society of Nephrology : JASN, 20(7):1453 - 64, Jul. 2009
• Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats., Kazim Husain; Leon Ferder; Masahide Mizobuchi; Jane Finch; Eduardo Slatopolsky, American journal of nephrology, 29(5):465 - 72, 2009
• Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification., Masanori Tokumoto; Masahide Mizobuchi; Jane L Finch; Hironori Nakamura; Daniel R Martin; Eduardo Slatopolsky, American journal of nephrology, 29(6):582 - 91, 2009
• Clinical significance of parathyroid intervention on CKD-MBD management., Hiroaki Ogata; Masahide Mizobuchi; Fumihiko Koiwa; Eriko Kinugasa; Tadao Akizawa, NDT plus, 1(Suppl 3):iii9-iii13, Aug. 2008
• Activation of calcium-sensing receptor accelerates apoptosis in hyperplastic parathyroid cells., Masahide Mizobuchi; Hiroaki Ogata; Ikuji Hatamura; Fumie Saji; Fumihiko Koiwa; Eriko Kinugasa; Shozo Koshikawa; Tadao Akizawa, Biochemical and biophysical research communications, 362(1):11 - 16, Oct. 2007
• Differential effects of vitamin D receptor activators on vascular calcification in uremic rats., M Mizobuchi; J L Finch; D R Martin; E Slatopolsky, Kidney international, 72(6):709 - 15, Sep. 2007
• Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats., Masahide Mizobuchi; Jeremiah Morrissey; Jane L Finch; Daniel R Martin; Helen Liapis; Tadao Akizawa; Eduardo Slatopolsky, Journal of the American Society of Nephrology : JASN, 18(6):1796 - 806, Jun. 2007
• Effect of 2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferol (2MbisP), an analog of vitamin D, on secondary hyperparathyroidism., Eduardo Slatopolsky; Jane L Finch; Alex J Brown; Cynthia S Ritter; Masahide Mizobuchi; Lori A Plum; Margaret Clagett-Dame; Rafal R Sicinski; Hector F DeLuca, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 22(5):686 - 94, May 2007
• Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism., Masahide Mizobuchi; Hiroaki Ogata; Ikuji Hatamura; Fumihiko Koiwa; Fumie Saji; Kazuhiro Shiizaki; Shigeo Negi; Eriko Kinugasa; Akira Ooshima; Shozo Koshikawa; Tadao Akizawa, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 21(4):911 - 6, Apr. 2006
• Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats., Kazuhiro Shiizaki; Shigeo Negi; Ikuji Hatamura; Toshifumi Sakaguchi; Fumie Saji; Ken Kunimoto; Masahide Mizobuchi; Ikuo Imazeki; Akira Ooshima; Tadao Akizawa, Journal of the American Society of Nephrology : JASN, 16(1):97 - 108, Jan. 2005
• Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiency., Masahide Mizobuchi; Ikuji Hatamura; Hiroaki Ogata; Fumie Saji; Susumu Uda; Kazuhiro Shiizaki; Toshifumi Sakaguchi; Shigeo Negi; Eriko Kinugasa; Shozo Koshikawa; Tadao Akizawa, Journal of the American Society of Nephrology : JASN, 15(10):2579 - 87, Oct. 2004
• Management of secondary hyperparathyroidism of dialysis patients., Tadao Akizawa; Motohiro Kamimura; Masahide Mizobuchi; Kazuhiro Shiizaki; Shinji Sumikado; Toshibumi Sakaguchi; Shigeo Negi; Hiroaki Ogata; Eriko Kinugasa, Nephrology (Carlton, Vic.), 8 Suppl:S53-7, Oct. 2003
• Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia., Kazuhiro Shiizaki; Ikuji Hatamura; Shigeo Negi; Nobuhiko Narukawa; Masahide Mizobuchi; Toshifumi Sakaguchi; Akira Ooshima; Tadao Akizawa, Kidney international, 64(3):992 - 1003, Sep. 2003
• Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients., Kazuhiro Shiizaki; Shigeo Negi; Masahide Mizobuchi; Ikuji Hatamura; Nobuhiko Narukawa; Toshifumi Sakaguchi; Yukiko Kitabata; Shinji Sumikado; Tadao Akizawa, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 18 Suppl 3:iii42-6, Jun. 2003
• New strategies for the treatment of secondary hyperparathyroidism., Tadao Akizawa; Kazuhiro Shiizaki; Ikuji Hatamura; Motohiro Kamimura; Masahide Mizobuchi; Nobuhiko Narukawa; Shinji Sumikado; Toshibumi Sakaguchi; Shigeo Negi; Hiroaki Ogata; Eriko Kinugasa, American journal of kidney diseases : the official journal of the National Kidney Foundation, 41(3 Suppl 1):S100-3, Mar. 2003
• 【Calcium sensing receptor】Ca receptorの局在と機能 副甲状腺, 小岩 文彦; 溝渕 正英; 衣笠 えり子; 出浦 照國, 腎と透析, 47(5):621 - 626, Nov. 1999

Presentations

• エボカルセトの,二次性副甲状腺機能亢進症モデルラットのカルシウム感知受容体とビタミンD受容体への影響, 齋藤 友広;溝渕 正英;酒井 まり子;川田 剛央;北山 哲也;加藤 憲;鈴木 泰平;緒方 浩顕;小岩 文彦;本田 浩一, 第66回日本腎臓学会学術総会, 09 Jun. 2023, 横浜
• 腎不全ラットの骨髄由来間葉系幹細胞におけるリン負荷の影響, 加藤　憲;溝渕　正英;朝倉　慶;和田　紗矢香;山本　真寛;伊藤　英利;上條　竜太郎;緒方　浩顕, 第62回日本腎臓学会学術総会, 22 Jun. 2019, 名古屋
• 腎不全病態ラットの骨髄由来間葉系幹細胞の骨芽細胞への分化能に対する影響, 加藤　憲;溝渕　正英;上條　竜太郎;緒方　浩顕, 第3回日本CKD-MBD研究会学術集会・総会, 02 Mar. 2019, 東京
• 二次性副甲状腺機能亢進症(SHPT)に対するエテルカルセチドの有用性に関する検討, 齋藤　友広;藤原　康朗;金森　直明;幕内　幹男;溝渕　正英;柴田　孝則, 第63回日本透析医学会学術集会・総会, 30 Jun. 2018, 神戸
• 腎移植から2年6ヵ月後に急性拒絶反応を発症した1例, 林　純一;溝渕　正英;濱田　透眞;鈴木　幸恵;角藤　哲;吉武　理;本田　一穂;山口　裕;柴田　孝則, 第46回日本腎臓学会東部学術大会, 08 Oct. 2016, 東京
• 進行性の結節性多発動脈炎(PN)に対して単純血漿交換療法が効果的であった一例, 角藤　哲;猪狩　雄蔵;徳永　剛広;古屋　秀和;三輪　裕介;稲葉　大朗;井芹　健;濱田　透眞;溝渕　正英;柴田　孝則, 第61回日本透析医学会学術集会・総会, 10 Jun. 2016, 大阪
• 重篤な肝不全を合併した常染色体優性多発性嚢胞腎による血液透析患者の1例, 齋藤　友広;猪口　貴子;橘　翔平;日原　桂;濱田　透眞;溝渕　正英;柴田　孝則, 第60回日本透析医学会学術集会・総会, 28 Jun. 2015, 横浜
• A case of severe secondary hyperparathyroidism which could been avoided PTx by percutaneous vitaminD injection therapy and low dose of calcimimetics, 松坂　貫太郎;和田　幸寛;熊田　千晶;小岩　文彦;溝渕　正英;緒方　浩顕;衣笠　えり子, 第40回日本腎臓学会東部学術大会, 25 Sep. 2010, 宇都宮